This inventor holds 1 USPTO granted patent and 7 published patent applications. Top assignees: Kinki University, Kobayashi Pharmaceutical Co., Ltd.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2023
Title: Masanobu Tsubaki: Innovator in Neuropathy Treatment
Introduction
Masanobu Tsubaki is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of medical science, particularly in the treatment of peripheral sensory neuropathy. His innovative approach addresses a critical need for effective therapies in this area.
Latest Patents
Tsubaki holds a patent for a composition aimed at ameliorating peripheral sensory neuropathy. This condition often arises as a side effect of anticancer drugs, such as oxaliplatin. His patented composition includes amycelium extract, which has shown promise in alleviating symptoms like numbness, pain in extremities, and impaired motor functions. This breakthrough offers hope for patients suffering from the debilitating effects of drug-induced neuropathy.
Career Highlights
Throughout his career, Tsubaki has been associated with esteemed institutions such as Kinki University and Kobayashi Pharmaceutical Co., Ltd. His work has been instrumental in advancing research and development in the medical field. His dedication to improving patient outcomes is evident in his innovative contributions.
Collaborations
Tsubaki has collaborated with notable colleagues, including Shozo Nishida and Tomoya Takeda. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of their work.
Conclusion
Masanobu Tsubaki's contributions to the treatment of peripheral sensory neuropathy highlight his role as a pioneering inventor in the medical field. His innovative solutions provide hope for patients affected by this challenging condition.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile